Clever Leaves Stock Intrinsic Value – Clever Leaves Receives Australian GMP Certification for Cannabis Products from TGA
January 5, 2024
☀️Trending News
Clever Leaves ($NASDAQ:CLVR), a leading cannabis company based in Colombia, has recently had its cannabis products certified with Good Manufacturing Practice (GMP) by the Therapeutic Goods Administration (TGA) of Australia. This certification is a major milestone for the company, as it will allow them to expand their reach to the Australian market. Their production processes are consistently monitored by their experienced team of scientists and engineers, with the goal of providing high quality cannabis products that meet the highest safety and efficacy standards.
Their strategic partnership with TGA to receive GMP certification will help ensure that their products are safe and effective for consumers in Australia. With this certification, Clever Leaves has positioned itself as one of the leading cannabis companies in the world, and they look forward to continuing to provide premium cannabis products to the global market.
Price History
On Wednesday, CLEVER LEAVES made a major announcement that was well received by the market; the company received Australian Good Manufacturing Practice (GMP) certification for their cannabis products from the Therapeutic Goods Administration (TGA). This is an essential step for their international expansion, as the certification allows them to expand their portfolio into the Australian market. The news had a positive impact on the stock prices; CLEVER LEAVES stock opened at $2.2 and closed at $2.3, soaring by 11.5% from the last closing price of 2.1. This is a strong sign of confidence in the company’s future prospects and their ability to continue to achieve success in the global cannabis sector. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Clever Leaves. More…
| Total Revenues | Net Income | Net Margin |
| 18.57 | -41.63 | -157.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Clever Leaves. More…
| Operations | Investing | Financing |
| -15.06 | 3.19 | 0.57 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Clever Leaves. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 37.78 | 8.09 | 17.2 |
Key Ratios Snapshot
Some of the financial key ratios for Clever Leaves are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 31.5% | – | -271.2% |
| FCF Margin | ROE | ROA |
| -79.2% | -98.9% | -83.3% |
Analysis – Clever Leaves Stock Intrinsic Value
At GoodWhale, we have conducted an analysis of CLEVER LEAVES‘ fundamentals. Based on this analysis, our proprietary Valuation Line gives a fair value of around $827.6 for a single share of CLEVER LEAVES. At the moment, CLEVER LEAVES stock is being traded at only $2.3. This indicates that the stock is currently undervalued by 99.7%. Therefore, investors should consider buying CLEVER LEAVES stock now, as it offers an excellent opportunity for long-term growth. More…
Peers
Clever Leaves Holdings Inc is an emerging player in the cannabis industry. It is the first major international player to enter the scene and compete with established companies such as Bhang Inc, Fiore Cannabis Ltd and Green Thumb Industries Inc. Its focus is on cultivating premium grade cannabis products, providing them to consumers at a competitive price.
– Bhang Inc ($OTCPK:BHNGF)
Bhang Inc is a US-based cannabis company that produces high-quality cannabis products such as edibles, flower, concentrates, and topicals. The company has achieved impressive financial results, which has led to an impressive market cap of 4.68M as of 2023. Moreover, its Return on Equity (ROE) of 212.6% is indicative of the company’s success in leveraging its assets and generating profits for its shareholders. This impressive ROE is well above the industry average, and has helped Bhang Inc’s stock to become one of the most sought-after investments in the cannabis sector.
– Fiore Cannabis Ltd ($OTCPK:FIORF)
Fiore Cannabis Ltd is a Canadian-based cannabis company that focuses on the production, distribution, and sale of medicinal cannabis products. The company’s market cap as of 2023 is 315.28k, which is indicative of the company’s growth and success over the years. Furthermore, the company has achieved a Return on Equity of 423.76%, which demonstrates the level of profitability achieved by the company. The company strives to provide premium quality products while adhering to the regulatory standards of their respective markets.
– Green Thumb Industries Inc ($OTCPK:GTBIF)
Green Thumb Industries Inc is a leading cannabis company that operates in 12 states across the US. It has a market cap of 1.88B as of 2023, which is a reflection of its strong position in the industry and its potential for future growth. The company’s Return on Equity (ROE) ratio is 4.81%, which is an indication of its ability to generate profits from its equity capital. Green Thumb Industries Inc’s operations are focused on manufacturing, distributing, and retailing cannabis products to customers across the United States. This diversified approach is helping the company to capture new markets and drive increased revenues.
Summary
Clever Leaves is a cannabis-focused company that has recently been granted GMP certification for their products by the Australian Therapeutic Goods Administration (TGA). This certification is necessary for the sale of cannabis products in Australia, and investors have responded positively to the news, with stock prices rising the same day. Analysts suggest that this certification could open up the Australian cannabis market for Clever Leaves, leading to strong growth potential in the future. With a stable management team and a focus on high-quality products, Clever Leaves is well positioned to take advantage of the growing demand in Australia’s cannabis market.
